TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans
Authors:
- Sébastien GibotSGSébastien Gibot
- Ismael AcevedoIAIsmael Acevedo
- James GattisJGJames Gattis
- Laura QuigleyLQLaura Quigley
- Robert FeltzRFRobert Feltz
- Alina De La MotaAMAlina De La Mota
- Rebecca L. SchubertRSRebecca L. Schubert
- Julio Gomez-RodriguezJGJulio Gomez-Rodriguez
- Jun ChengJCJun Cheng
- Amalia DutraADAmalia Dutra
- Evgenia PakEPEvgenia Pak
Open Access
- 1 June 2009
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 119 (6) , 1489-1501
Abstract
Triggering receptor expressed on myeloid cells–like (TREM-like) transcript-1 (TLT-1), a type 1 single Ig domain orphan receptor specific to platelet and megakaryocyte α-granules, relocates to the platelet surface upon platelet stimulation. We found here that patients diagnosed with sepsis, in contrast to healthy individuals, had substantial levels of soluble TLT-1 (sTLT-1) in their plasma that correlated with the presence of disseminated intravascular coagulation. sTLT-1 bound to fibrinogen and augmented platelet aggregation in vitro. Furthermore, the cytoplasmic domain of TLT-1 could also bind ezrin/radixin/moesin family proteins, suggesting its ability to link fibrinogen to the platelet cytoskeleton. Accordingly, platelets of Treml1–/– mice failed to aggregate efficiently, extending tail-bleeding times. Lipopolysaccharide-treated Treml1–/– mice developed higher plasma levels of TNF and D-dimers than wild-type mice and were more likely to succumb during challenge. Finally, Treml1–/– mice were predisposed to hemorrhage associated with localized inflammatory lesions. Taken together, our findings suggest that TLT-1 plays a protective role during inflammation by dampening the inflammatory response and facilitating platelet aggregation at sites of vascular injury. Therefore, therapeutic modulation of TLT-1–mediated effects may provide clinical benefit to patients with hypercoagulatory conditions, including those associated with inflammation.Keywords
This publication has 39 references indexed in Scilit:
- Inflammation induces hemorrhage in thrombocytopeniaBlood, 2008
- Phenotypic heterogeneity in the gray platelet syndrome extends to the expression of TREM family member, TLT-1Thrombosis and Haemostasis, 2008
- Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotypeNature Medicine, 2007
- A TREM family member, TLT-1, is found exclusively in the α-granules of megakaryocytes and plateletsBlood, 2004
- Analytic Validation and Clinical Evaluation of the STA LIATEST Immunoturbidimetric D-Dimer Assay for the Diagnosis of Disseminated Intravascular CoagulationAmerican Journal of Clinical Pathology, 2004
- Analytic Validation and Clinical Evaluation of the STA LIATEST Immunoturbidimetric D-Dimer Assay for the Diagnosis of Disseminated Intravascular CoagulationAmerican Journal of Clinical Pathology, 2004
- Platelet moesin interacts with PECAM-1 (CD31)Platelets, 2003
- Initial characterization of TREM-like transcript (TLT)–1: a putative inhibitory receptor within the TREM clusterBlood, 2002
- Disseminated Intravascular CoagulationNew England Journal of Medicine, 1999
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996